Journey Medical: Emrosi Is Winning, But The Stock Hasn't Noticed

Most microcap biopharma stocks are binary bets. You either get a drug approval and a buyout or you get a failed trial and a zero. Journey Medical ( DERM ) is different, and I thinkI'm a fundamental investor who targets situations where the market has pushed a company’s valuation far out of line with its underlying economics. My professional background in corporate financial analysis has deeply shaped my investment perspective, leading me to focus intensely on cash flow durability, balance sheet strength, an ...